BamSEC and AlphaSense Join Forces
Learn More

Rocket Pharmaceuticals Inc.

NASDAQ: RCKT    
Share price (12/27/24): $11.75    
Market cap (12/27/24): $1.071 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 9 pages Executive Employment Agreement
12/34/56
EX-10.23
from 10-K 4 pages Rocket Pharmaceuticals, Inc. General Compensation Clawback Policy Amended and Restated Effective September 25, 2023
12/34/56
EX-10.13
from 10-K 8 pages Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Severance and Change in Control Program
12/34/56
EX-10.1
from 8-K 42 pages Rocket Pharmaceuticals, Inc. $200,000,000 Shares Common Stock Sales Agreement
12/34/56
EX-10.27
from 10-K 10 pages Rocket Pharmaceuticals, Inc. Warrant to Purchase Shares
12/34/56
EX-10.26
from 10-K 10 pages Rocket Pharmaceuticals, Inc. Warrant to Purchase Shares
12/34/56
EX-10.12
from 10-K 2 pages April 29, 2021 Isabel Carmona
12/34/56
EX-10.10
from 10-K 3 pages Rocket Pharmaceuticals Ltd C/O Co Services Cayman Limited P.O. Box 10008 Willow House Cricket Square Grand Cayman Kyi-1001 Cayman Islands
12/34/56
EX-10.2
from 8-K 12 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 18 pages Securities Purchase Agreement
12/34/56
EX-10.23
from 10-K 10 pages Rocket Pharmaceuticals, Inc. Warrant to Purchase Shares
12/34/56
EX-10.11
from 10-K 2 pages Material contract
12/34/56
EX-10.2
from 10-Q 7 pages Rocket Pharmaceuticals, Inc. Consulting Agreement
12/34/56
EX-10.10
from 10-K 3 pages September 25, 2019 1. Position. 2. Compensation
12/34/56
EX-10.6.1
from 10-K 11 pages Rocket Pharmaceuticals, Inc. Second Amended and Restated 2014 Stock Option and Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.1
from 8-K 30 pages Form of Exchange Agreement
12/34/56
EX-10.1
from 10-Q 55 pages Pursuant to 17 Cfr 229.601, Certain Identified Information Marked “[***]” Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Contents
12/34/56
EX-10.26
from 10-K 40 pages License Agreement Article 1: Definitions
12/34/56
EX-10.19
from 10-K 8 pages Form of Severance and Change in Control Agreement
12/34/56